MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2741/3456

Медицинская библиотека · Frontiers in bioscience (Landmark edition) · 2009

Control of cell death pathways by HTLV-1 proteins.

Kapellusch Jay M, Gerr Frederic E, Malloy Elizabeth J, Garg Arun, Harris-Adamson Carisa, Bao Stephen S, Burt Susan E, Dale Ann Marie, Eisen Ellen A, Evanoff Bradley A, Hegmann Kurt T, Silverstein Barbara A, Theise Matthew S, Rempel David M

СтатьяПоддержка исследования: вне правительства СШАОбзорПеревод пока не подготовлен

Аннотация

The indications for revision middle ear surgery are inter-linked to the objectives of surgery and needs of the patient. Revision middle ear surgery is often challengingly arduous not only for the patient but for the surgeon as well. This study concentrates on the causes of failures of primary ear surgery, indications, techniques, outcomes and lessons learned in revision ear surgery. This retrospectivedescriptive study included 22 cases (12.29%) of revision surgery,with a follow up of at least one year, out of total 179 cases of middle ear surgeries performed over a period of 5 years.These revision cases included tympanoplasty, cortical mastoidectomy and modified radical mastoidectomy alongwith ossiculoplasty and scutumplasty, wherever required. Hearing improvement, closure of perforation, and prevention of recrudescence were the main outcome parameters. The overall morphologic success of revision surgery in our series was 90.90%.There was one graft failure, one attic retraction and the main complication observed was post-operative worsening of hearing.Mean postoperative pure-tone average air -bone gap (ABG) was 20.86 ± 11.29 dB compared with preoperative ABG of 29.64 ± 10.63 dB and the difference was statistically significant ( p < 0.05) with p value 0.0112 on paired t-test. Detailed knowledge and anticipation of the cause of failure is a must in preventing another failure in revision ear surgeries. Hearing preservation must be considered in a pragmatic perspective and accordingly surgical indications must complement the realistic and reasonable expectations of the patients.

Для цитирования: Kapellusch Jay M, Gerr Frederic E, Malloy Elizabeth J, Garg Arun, Harris-Adamson Carisa, Bao Stephen S, Burt Susan E, Dale Ann Marie, Eisen Ellen A, Evanoff Bradley A, Hegmann Kurt T, Silverstein Barbara A, Theise Matthew S, Rempel David M. Control of cell death pathways by HTLV-1 proteins.. Frontiers in bioscience (Landmark edition). 2009. DOI: 10.2741/3456.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.